Order Article Reprints

Hoshi K, Ito H, Abe E, Fuwa TJ, Kanno M, Murakami Y, Abe M, Murakami T, Yoshihara A, Ugawa Y, et al. Transferrin Biosynthesized in the Brain Is a Novel Biomarker for Alzheimer’s Disease. Metabolites. 2021; 11(9):616. https://doi.org/10.3390/metabo11090616

Hoshi, Kyoka, Hiromi Ito, Eriko Abe, Takashi J. Fuwa, Mayumi Kanno, Yuta Murakami, Mitsunari Abe, Takenobu Murakami, Akioh Yoshihara, Yoshikazu Ugawa, and et al. 2021. "Transferrin Biosynthesized in the Brain Is a Novel Biomarker for Alzheimer’s Disease" Metabolites 11, no. 9: 616. https://doi.org/10.3390/metabo11090616

Hoshi, K., Ito, H., Abe, E., Fuwa, T. J., Kanno, M., Murakami, Y., Abe, M., Murakami, T., Yoshihara, A., Ugawa, Y., Saito, T., Saido, T. C., Matsumoto, K., Yamaguchi, Y., Furukawa, K., Arai, H., Kanai, M., Miyajima, M., Arai, H., ... Hashimoto, Y. (2021). Transferrin Biosynthesized in the Brain Is a Novel Biomarker for Alzheimer’s Disease. Metabolites, 11(9), 616. https://doi.org/10.3390/metabo11090616